532 related articles for article (PubMed ID: 26058042)
41. Riociguat for treatment of pulmonary hypertension in COPD: a translational study.
Pichl A; Sommer N; Bednorz M; Seimetz M; Hadzic S; Kuhnert S; Kraut S; Roxlau ET; Kojonazarov B; Wilhelm J; Gredic M; Gall H; Tello K; Richter MJ; Pak O; Petrovic A; Hecker M; Schermuly RT; Grimminger F; Seeger W; Ghofrani HA; Weissmann N
Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 30956210
[TBL] [Abstract][Full Text] [Related]
42. Cigarette smoke exposure alters phosphodiesterases in human structural lung cells.
Zuo H; Faiz A; van den Berge M; Mudiyanselage SNHR; Borghuis T; Timens W; Nikolaev VO; Burgess JK; Schmidt M
Am J Physiol Lung Cell Mol Physiol; 2020 Jan; 318(1):L59-L64. PubMed ID: 31664853
[TBL] [Abstract][Full Text] [Related]
43. Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease.
Bracke KR; Verhamme FM; Seys LJ; Bantsimba-Malanda C; Cunoosamy DM; Herbst R; Hammad H; Lambrecht BN; Joos GF; Brusselle GG
Am J Respir Crit Care Med; 2013 Aug; 188(3):343-55. PubMed ID: 23742729
[TBL] [Abstract][Full Text] [Related]
44. Vitamin C prevents cigarette smoke-induced pulmonary emphysema in mice and provides pulmonary restoration.
Koike K; Ishigami A; Sato Y; Hirai T; Yuan Y; Kobayashi E; Tobino K; Sato T; Sekiya M; Takahashi K; Fukuchi Y; Maruyama N; Seyama K
Am J Respir Cell Mol Biol; 2014 Feb; 50(2):347-57. PubMed ID: 24032444
[TBL] [Abstract][Full Text] [Related]
45. Susceptibility to pulmonary hypertension in inbred strains of mice exposed to cigarette smoke.
Nadziejko C; Fang K; Bravo A; Gordon T
J Appl Physiol (1985); 2007 May; 102(5):1780-5. PubMed ID: 17272409
[TBL] [Abstract][Full Text] [Related]
46. Novel peptide for attenuation of hypoxia-induced pulmonary hypertension via modulation of nitric oxide release and phosphodiesterase -5 activity.
Hu H; Zharikov S; Patel JM
Peptides; 2012 May; 35(1):78-85. PubMed ID: 22465621
[TBL] [Abstract][Full Text] [Related]
47. Cigarette smoke extract-treated mast cells promote alveolar macrophage infiltration and polarization in experimental chronic obstructive pulmonary disease.
Li H; Yang T; Ning Q; Li F; Chen T; Yao Y; Sun Z
Inhal Toxicol; 2015; 27(14):822-31. PubMed ID: 26671198
[TBL] [Abstract][Full Text] [Related]
48. Additive effect of tadalafil and simvastatin on monocrotaline-induced pulmonary hypertension rats.
Zhang WH; Liu CP; Zhang YJ; Ji YQ; Lu WX; Zeng Q
Scand Cardiovasc J; 2012 Dec; 46(6):374-80. PubMed ID: 22971207
[TBL] [Abstract][Full Text] [Related]
49. Phosphodiesterase 4 inhibitor GPD-1116 markedly attenuates the development of cigarette smoke-induced emphysema in senescence-accelerated mice P1 strain.
Mori H; Nose T; Ishitani K; Kasagi S; Souma S; Akiyoshi T; Kodama Y; Mori T; Kondo M; Sasaki S; Iwase A; Takahashi K; Fukuchi Y; Seyama K
Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L196-204. PubMed ID: 17993591
[TBL] [Abstract][Full Text] [Related]
50. Enhanced deposition of low-molecular-weight hyaluronan in lungs of cigarette smoke-exposed mice.
Bracke KR; Dentener MA; Papakonstantinou E; Vernooy JH; Demoor T; Pauwels NS; Cleutjens J; van Suylen RJ; Joos GF; Brusselle GG; Wouters EF
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):753-61. PubMed ID: 19675307
[TBL] [Abstract][Full Text] [Related]
51. Cigarette smoke induction of S100A9 contributes to chronic obstructive pulmonary disease.
Railwah C; Lora A; Zahid K; Goldenberg H; Campos M; Wyman A; Jundi B; Ploszaj M; Rivas M; Dabo A; Majka SM; Foronjy R; El Gazzar M; Geraghty P
Am J Physiol Lung Cell Mol Physiol; 2020 Dec; 319(6):L1021-L1035. PubMed ID: 32964723
[TBL] [Abstract][Full Text] [Related]
52. DA-8159, a new PDE5 inhibitor, attenuates the development of compensatory right ventricular hypertrophy in a rat model of pulmonary hypertension.
Kang KK; Ahn GJ; Sohn YS; Ahn BO; Kim WB
J Int Med Res; 2003; 31(6):517-28. PubMed ID: 14708417
[TBL] [Abstract][Full Text] [Related]
53. Combined inhibition of PDE4 and PI3Kδ modulates the inflammatory component involved in the progression of chronic obstructive pulmonary disease.
Dinavahi SS; Nyayapathy S; Perumal Y; Dharmarajan S; Viswanadha S
Drug Res (Stuttg); 2014 Apr; 64(4):214-9. PubMed ID: 24105104
[TBL] [Abstract][Full Text] [Related]
54. Protein Phosphatase 2A Reduces Cigarette Smoke-induced Cathepsin S and Loss of Lung Function.
Doherty DF; Nath S; Poon J; Foronjy RF; Ohlmeyer M; Dabo AJ; Salathe M; Birrell M; Belvisi M; Baumlin N; Kim MD; Weldon S; Taggart C; Geraghty P
Am J Respir Crit Care Med; 2019 Jul; 200(1):51-62. PubMed ID: 30641028
[No Abstract] [Full Text] [Related]
55. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
[TBL] [Abstract][Full Text] [Related]
56. Ghrelin ameliorates catabolic conditions and respiratory dysfunction in a chronic obstructive pulmonary disease model of chronic cigarette smoke-exposed rats.
Kamiide Y; Inomata N; Furuya M; Yada T
Eur J Pharmacol; 2015 May; 755():88-94. PubMed ID: 25771457
[TBL] [Abstract][Full Text] [Related]
57. Emphysema and metalloelastase expression in mouse lung induced by cigarette smoke.
Valença SS; da Hora K; Castro P; Moraes VG; Carvalho L; Porto LC
Toxicol Pathol; 2004; 32(3):351-6. PubMed ID: 15204978
[TBL] [Abstract][Full Text] [Related]
58. Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure.
Triposkiadis F; Xanthopoulos A; Skoularigis J; Starling RC
Heart Fail Rev; 2022 Nov; 27(6):1991-2003. PubMed ID: 35437713
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension.
Bubb KJ; Trinder SL; Baliga RS; Patel J; Clapp LH; MacAllister RJ; Hobbs AJ
Circulation; 2014 Aug; 130(6):496-507. PubMed ID: 24899690
[TBL] [Abstract][Full Text] [Related]
60. Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in mice.
Hadzic S; Wu CY; Gredic M; Pak O; Loku E; Kraut S; Kojonazarov B; Wilhelm J; Brosien M; Bednorz M; Seimetz M; Günther A; Kosanovic D; Sommer N; Warburton D; Li X; Grimminger F; Ghofrani HA; Schermuly RT; Seeger W; El Agha E; Bellusci S; Weissmann N
Eur Respir J; 2023 Nov; 62(5):. PubMed ID: 37884305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
